8-K: Enveric Biosciences Changes Auditors, Appoints CBIZ CPAs

Enveric Biosciences dismisses Marcum LLP as its independent auditor and engages CBIZ CPAs, effective April 14, 2025.

Summary

• Enveric Biosciences has changed its independent registered public accounting firm.
• Marcum LLP was dismissed on April 14, 2025.
• CBIZ CPAs was engaged as the new independent registered public accounting firm, effective immediately on April 14, 2025, for the year ending December 31, 2025.
• The Audit Committee of the Company's Board of Directors approved the engagement of CBIZ CPAs.
• The services previously provided by Marcum will now be provided by CBIZ CPAs.
• Marcum's report for the fiscal year ended December 31, 2024, included an explanatory paragraph relating to substantial doubt about the Company's ability to continue as a going concern.
• Management concluded that there existed material weakness in internal controls over financial reporting for the fiscal years ended December 31, 2023 and December 31, 2024.

Sentiment

Score: 3

Explanation: The change in auditors coupled with the going concern qualification and material weaknesses in internal controls suggests a negative outlook.

Positives

• The engagement of a new auditor may bring a fresh perspective to the company's financial oversight.

Negatives

• The inclusion of an explanatory paragraph in Marcum's report for the fiscal year ended December 31, 2024, indicates substantial doubt about the company's ability to continue as a going concern.
• The identified material weaknesses in internal controls over financial reporting for the fiscal years ended December 31, 2023 and December 31, 2024, are a concern.

Risks

• The material weaknesses in internal controls could lead to errors or fraud in financial reporting.
• The going concern qualification raises concerns about the company's long-term viability.

Industry Context

Changes in auditors are not uncommon, but they often signal a need for improved financial oversight or a change in strategic direction. The acquisition of Marcum's attest business by CBIZ CPAs is part of the ongoing consolidation within the accounting industry.

Comparison to Industry Standards

• The engagement of a new auditor is a standard corporate governance practice.
• Companies like Pfizer, Johnson & Johnson, and Merck also undergo periodic auditor changes to ensure independence and objectivity.
• The presence of a 'going concern' paragraph is a serious issue that requires immediate attention and remediation, as it raises questions about the company's financial stability compared to industry peers.

Stakeholder Impact

• Shareholders may be concerned about the company's financial stability and internal controls.
• Employees may experience uncertainty due to the going concern qualification.
• Creditors may be hesitant to extend credit to the company.

Key Dates

Keywords

auditor, CBIZ CPAs, Marcum LLP, independent registered public accounting firm, internal controls, going concern, financial reporting, Enveric Biosciences